Complement inhibitors finally find orphan niches
نویسندگان
چکیده
منابع مشابه
Finally, Faces Find Favor
Historical trends in face perception research during the past half century are summarized. The dual process model offered by cognitive neuroscientists to account for the perception of identity and emotion expression in the face is briefly reviewed together with supporting evidence. An ecological approach that incorporates missing pieces of face perception is offered as an additional, broader co...
متن کاملHelp Developers (finally) Find Their Own Performance Defects
How early in the software development cycle are most performance defects found? Before or after QA? Industry pundits have long sought to reduce costs by fixing software defects earlier in the cycle. The path to these cost reductions, however, is fraught with road blocks. This paper focuses on a concrete testing regimen that works around these longstanding obstacles. It empowers developers to fi...
متن کاملThe testate lobose amoebae (order Arcellinida Kent, 1880) finally find their home within Amoebozoa.
Testate lobose amoebae (order Arcellinida Kent, 1880) are common in all aquatic and terrestrial habitats, yet they are one of the last higher taxa of unicellular eukaryotes that has not found its place in the tree of life. The morphological approach did not allow to ascertain the evolutionary origin of the group or to prove its monophyly. To solve these challenging problems, we analyzed partial...
متن کاملComplement inhibitors for age-related macular degeneration.
BACKGROUND Given the relatively high prevalence of age-related macular degeneration (AMD) and the increased incidence of AMD as populations age, the results of trials of novel treatments are awaited with much anticipation. The complement cascade describes a series of proteolytic reactions occurring throughout the body that generate proteins with a variety of roles including the initiation and p...
متن کاملComplement receptor 2-mediated targeting of complement inhibitors to sites of complement activation.
In a strategy to specifically target complement inhibitors to sites of complement activation and disease, recombinant fusion proteins consisting of a complement inhibitor linked to a C3 binding region of complement receptor (CR) 2 were prepared and characterized. Natural ligands for CR2 are C3 breakdown products deposited at sites of complement activation. Fusion proteins were prepared consisti...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Nature Biotechnology
سال: 2006
ISSN: 1087-0156,1546-1696
DOI: 10.1038/nbt0406-371